Canopy Growth (CGC) Change in Accured Expenses (2019 - 2025)

Canopy Growth (CGC) reported Change in Accured Expenses of -$1.6 million for Q4 2025, down 143.64% on a YoY basis from $3.6 million in Q4 2024, and down 141.74% sequentially from $3.7 million in Q2 2025.

Canopy Growth (CGC) Change in Accured Expenses (2019 - 2025) Analysis & Trends

Canopy Growth (CGC) has 7 years of Change in Accured Expenses data on file, last reported at -$1.6 million in Q4 2025.

  • For the quarter ending Q4 2025, Change in Accured Expenses fell 143.64% year-over-year to -$1.6 million; the trailing twelve-month figure through Dec 2025 stood at -$6.0 million (up 6.19% YoY), and the FY2026 full-year result was -$3.2 million, up 70.58% from the prior year.
  • Change in Accured Expenses slipped to -$1.6 million in Q4 2025, from $3.7 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $10.7 million in Q3 2021 to a low of -$27.4 million in Q4 2021.
  • A 5-year average of -$3.2 million and a median of -$2.9 million in 2022 frame the typical range for Change in Accured Expenses.
  • Across the five-year window, Change in Accured Expenses jumped 983.78% in 2021 and tumbled 453.49% in 2022, its largest moves.
  • Tracing CGC's Change in Accured Expenses over 5 years: stood at -$27.4 million in 2021, then jumped by 84.85% to -$4.2 million in 2022, then soared by 346.37% to $10.2 million in 2023, then slumped by 65.02% to $3.6 million in 2024, then tumbled by 143.64% to -$1.6 million in 2025.
  • Business Quant data shows CGC's Change in Accured Expenses at -$1.6 million in Q4 2025, $3.7 million in Q2 2025, and $3.6 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Haleon 88.97 Bn 87.10 Bn - -
2 Teva Pharmaceutical Industries 35.95 Bn 32.21 Bn 1.97 Bn -144.00 Mn
3 Zoetis 32.26 Bn 30.32 Bn 1.62 Bn -234.00 Mn
4 Takeda Pharmaceutical 27.54 Bn 23.48 Bn 4.39 Bn -
5 United Therapeutics 23.15 Bn 21.00 Bn 648.10 Mn -12.70 Mn
6 RedHill Biopharma 20.53 Bn 20.53 Bn - -
7 Viatris 20.27 Bn 18.46 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.86 Bn 16.55 Bn 800.70 Mn -14.30 Mn
9 Elanco Animal Health 12.66 Bn 12.23 Bn 785.00 Mn -
10 Canopy Growth 269.64 Mn 3.71 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.56 Mn
Dec 31, 2025 -1.56 Mn
Jun 30, 2025 3.74 Mn
Jun 30, 2025 3.74 Mn
Dec 31, 2024 3.58 Mn
Dec 31, 2024 3.58 Mn
Sep 30, 2024 -11.79 Mn
Sep 30, 2024 -11.79 Mn
Jun 30, 2024 -4.32 Mn
Jun 30, 2024 -4.32 Mn
Mar 31, 2024 6.10 Mn
Mar 31, 2024 6.10 Mn
Dec 31, 2023 10.23 Mn
Dec 31, 2023 10.23 Mn
Sep 30, 2023 3.71 Mn
Sep 30, 2023 3.71 Mn
Jun 30, 2023 -13.41 Mn
Jun 30, 2023 -13.41 Mn
Mar 31, 2023 -6.77 Mn
Mar 31, 2023 -6.77 Mn